Filing Details
- Accession Number:
- 0001209191-18-019270
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-13 17:12:32
- Reporting Period:
- 2018-03-12
- Accepted Time:
- 2018-03-13 17:12:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1626971 | Corvus Pharmaceuticals Inc. | CRVS | () | G7 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1388325 | A/S Holdings Novo | Tuborg Havnevej 19 Hellerup G7 2900 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-12 | 1,176,470 | $8.50 | 4,420,516 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents a purchase from the underwriters in the Issuer's secondary offering.
Billionaire Hedge Funds
